Grindeks AS was founded in 1991 and is one of the leading pharmaceutical companies in the Baltic States. It is engaged in research, development, manufacturing and sales of medicament and active pharmaceutical ingredients. It is specialized in the heart and cardiovascular, psychotropic and anti-cancer therapeutic groups of medications. Grindeks AS has four subsidiaries and its export comprises 95% of the total turnover.
Since 1998 Grindeks AS is listed on the NASDAQ OMX Baltic stock exchange.
Headquarters
Krustpils str. 53
Riga; Riga;
Postal Code: LV-1057
Contact Details: Purchase the Grindeks AS report to view the information.
Website: http://www.grindeks.lv
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service